NCT00463918View on ClinicalTrials.gov

A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

December 31, 2007

Conditions
Smoking Cessation
Interventions
DRUG

varenicline

Trial Locations (16)

32607

Pfizer Investigational Site, Gainesville

32720

Pfizer Investigational Site, DeLand

36201

Pfizer Investigational Site, Anniston

36207

Pfizer Investigational Site, Anniston

40004

Pfizer Investigational Site, Bardstown

40509

Pfizer Investigational Site, Lexington

66212

Pfizer Investigational Site, Overland Park

71913

Pfizer Investigational Site, Hot Springs

78209

Pfizer Investigational Site, San Antonio

85013

Pfizer Investigational Site, Phoenix

90211

Pfizer Investigational Site, Los Angeles

92801

Pfizer Investigational Site, Anaheim

96813

Pfizer Investigational Site, Honolulu

96826

Pfizer Investigational Site, Honolulu

06511-5473

Pfizer Investigational Site, New Haven

SL1 2AD

Pfizer Investigational Site, Slough

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY